California State University - Interdisciplinary Cancer Meeting (CSU-ICM)
加州州立大学 - 跨学科癌症会议 (CSU-ICM)
基本信息
- 批准号:10539868
- 负责人:
- 金额:$ 0.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvocateBasic ScienceBiological SciencesBiomedical ResearchCOVID-19CaliforniaCamellia sinensisCancer BiologyCancer ScienceCancer SurvivorClinicalCollaborationsCommunitiesDataDevelopmentDisciplineDoctor of PhilosophyEarly DiagnosisEnsureEventFacultyFeedbackFosteringFundingGeographyGrantInstitutesInstitutionInvestigationKnowledgeLeadLearningLifeMalignant NeoplasmsNeoplasm MetastasisOncologyParticipantPatientsPerformancePreparationResearchResearch PersonnelResistanceSchoolsScientific Advances and AccomplishmentsScientistSeminalSiteUnited States National Institutes of HealthUniversitiesVisceralWorkanticancer researchbasecancer typecareer networkingdemographicsdesigngraduate studentinnovationinsightinter-institutionalinterdisciplinary approachlectureslow socioeconomic statusmeetingsmortalitynovelpostersprogramsracial disparitysocioeconomicssuccesssymposiumtumortumor microenvironmentundergraduate studentunderrepresented minority studentvirtual
项目摘要
R13 Application
Kelber, Tamae, De Bellard
Title: The California State University – Interdisciplinary Cancer Meeting (CSU-ICM)
PROJECT SUMMARY
The average mortality across all cancer types remains at over 30%. To develop
transformative solutions to central problems in oncology research, we have established
the biennial California State University – Interdisciplinary Cancer Meeting (CSU-ICM).
This application is to support the 2022 meeting on The Tumor Microenvironment:
Challenges and Opportunities that will be held on Friday, October 21 at the California
State University Northridge, Plaza del Sol Performance Hall. This meeting addresses the
need for cancer research meetings that provide affordable and focused platforms for
interdisciplinary exchange between life scientists, non-life scientists and cancer experts.
The inaugural 2018 CSU-ICM welcomed Dr. Joan Brugge and over 150 participants. The
second CSU-ICM in 2020 was virtual due to COVID19 but was a big success and
welcomed Dr. Carlos Arteaga and over 70 participants. This application is based upon
preliminary data collected from the 2018 and 2020 events demonstrating diversity of
participation at ethnic, discipline, geographic and institute levels. We postulate that
strategic expansion of this meeting will stimulate novel, collaborative lines of investigation
that lead to transformative advances in cancer research and increase diversity in
oncology research. The short talk sessions will be chaired by faculty leaders and
designed around trainee presentations - increasing the upward mobility of those
traditionally underrepresented in cancer research. Involvement of cancer survivor-
advocates will underscore the need to ensure that even the most basic science research
is grounded in clear personal perspective. The world-renowned plenary speakers ensure
the highest quality of scientific exchange. The graduate school information session will
provide a tangible conduit for undergraduate and masters-level graduate students to gain
meaningful insights about program and application details from faculty representatives at
top-tier R1 institutions. Finally, the poster session is designed to foster scientific
exchange, networking opportunities and constructive feedback on work-in-progress. In
summary, the CSU-ICM is designed to advance scientific knowledge, learning, and
discovery; promotion of professional development; and preparation of a diverse scientific
workforce while also fulfilling an important need in the broader cancer research
community.
R13应用
凯尔伯、塔梅、德·贝拉德
标题:加州州立大学-跨学科癌症会议(CSU-ICM)
项目总结
所有癌症类型的平均死亡率保持在30%以上。发展,发展
肿瘤学研究中中心问题的变革性解决方案,我们已经建立
两年一度的加州州立大学-跨学科癌症会议(CSU-ICM)。
这个应用是为了支持2022年肿瘤微环境会议:
挑战和机遇将于10月21日(星期五)在加利福尼亚州
北岭州立大学广场索尔演奏厅。这次会议讨论了
需要癌症研究会议,为以下方面提供负担得起的重点平台
生命科学家、非生命科学家和癌症专家之间的跨学科交流。
2018年首届CSU-ICM欢迎Joan Brugge博士和150多名与会者。这个
由于COVID19,2020年的第二次CSU-ICM是虚拟的,但取得了巨大成功
欢迎卡洛斯·阿特加博士和70多名与会者。此应用程序基于
从2018年和2020年的活动中收集的初步数据表明
在种族、学科、地域和机构层面上的参与。我们假定
本次会议的战略性扩展将促进新的、协作的调查路线
这导致了癌症研究的变革性进展,并增加了
肿瘤学研究。简短的讲座将由教职员工领导和
围绕学员演示设计-提高学员的向上流动性
传统上在癌症研究中的代表性不足。癌症幸存者的参与-
倡导者将强调,需要确保即使是最基础的科学研究
是基于清晰的个人观点。世界知名的全体演讲者确保
最高质量的科学交流。研究生院信息交流会
为本科生和硕士研究生提供实实在在的渠道
教职员工代表对课程和应用程序细节的有意义的见解
一流的R1机构。最后,海报会议的目的是促进科学
交流、建立联系的机会和对正在进行的工作的建设性反馈。在……里面
总之,CSU-ICM旨在促进科学知识、学习和
发现;促进专业发展;以及准备多样化的科学
同时还满足了更广泛的癌症研究中的重要需求
社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan Kelber其他文献
Jonathan Kelber的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan Kelber', 18)}}的其他基金
Non-Transcriptional Mechanisms of PEAK1 Action During TGFbeta-Induced EMT
TGFbeta 诱导的 EMT 过程中 PEAK1 作用的非转录机制
- 批准号:
9208078 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10546451 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10724839 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10545794 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10088942 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10613025 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
Spatiotemporal mechanisms of eIF5A1/2-mediated metastasis in triple-negative breast cancer
eIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10360453 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
SPATIOTEMPORAL MECHANISMS OF EIF5A1/2-MEDIATED METASTASIS IN TRIPLE-NEGATIVE BREAST CANCER
EIF5A1/2介导的三阴性乳腺癌转移的时空机制
- 批准号:
10374539 - 财政年份:2017
- 资助金额:
$ 0.5万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 0.5万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 0.5万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 0.5万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 0.5万 - 项目类别: